Activity
-
🚀 Exciting News from Medlior! 🚀 We’re thrilled to announce the addition of 640 new datasets to Real World Radar, Medlior’s digital directory of…
🚀 Exciting News from Medlior! 🚀 We’re thrilled to announce the addition of 640 new datasets to Real World Radar, Medlior’s digital directory of…
Liked by Phil Garner
-
That's a wrap on #ISPEAnnual2024! It's been a great event, bringing together experts from around the globe to discuss key issues in…
That's a wrap on #ISPEAnnual2024! It's been a great event, bringing together experts from around the globe to discuss key issues in…
Liked by Phil Garner
-
It’s the final day of the International Society for Pharmacoepidemiology Annual Conference, but there’s still lots to look forward to… Recaps of…
It’s the final day of the International Society for Pharmacoepidemiology Annual Conference, but there’s still lots to look forward to… Recaps of…
Liked by Phil Garner
Erleben Sie
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Bildung
More activity by Phil
-
As part of its #RealWorldEvidence efforts, the FDA announced four new Cooperative Agreement awards in 2023 to explore the use of #RealWorldData for…
As part of its #RealWorldEvidence efforts, the FDA announced four new Cooperative Agreement awards in 2023 to explore the use of #RealWorldData for…
Liked by Phil Garner
-
Day 2 of the International Society for Pharmacoepidemiology Annual Meeting 2024 was another jam-packed program of content, which today included a…
Day 2 of the International Society for Pharmacoepidemiology Annual Meeting 2024 was another jam-packed program of content, which today included a…
Liked by Phil Garner
-
I am biased on AI of course 😉but agree with you on the choice of ground breaking paper. Inspirational work from Bill Malcolm and team
I am biased on AI of course 😉but agree with you on the choice of ground breaking paper. Inspirational work from Bill Malcolm and team
Liked by Phil Garner
-
Day 2 is underway at #ISPEAnnual2024! Our recap of Day 1 is available now on The Evidence Base, and be sure and check back later to read our…
Day 2 is underway at #ISPEAnnual2024! Our recap of Day 1 is available now on The Evidence Base, and be sure and check back later to read our…
Liked by Phil Garner
-
Check out our Editor Laura Dormer's picks from the latest issue of the Journal of Comparative Effectiveness Research, including an Editorial on…
Check out our Editor Laura Dormer's picks from the latest issue of the Journal of Comparative Effectiveness Research, including an Editorial on…
Liked by Phil Garner
-
Great first day at #ICPE2024 in sunny Berlin 🕶️ with Florence Ma Saniya Deshpande We kicked off LCP’s contribution to the conference by presenting…
Great first day at #ICPE2024 in sunny Berlin 🕶️ with Florence Ma Saniya Deshpande We kicked off LCP’s contribution to the conference by presenting…
Liked by Phil Garner
-
Day 1 of #ISPEAnnual2024 is now complete! The Evidence Base editor Laura Dormer had a great start to the International Society for…
Day 1 of #ISPEAnnual2024 is now complete! The Evidence Base editor Laura Dormer had a great start to the International Society for…
Liked by Phil Garner
-
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved #lecanemab, the first drug designed to slow the progression of…
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved #lecanemab, the first drug designed to slow the progression of…
Liked by Phil Garner
Other similar profiles
Gemeinsame Artikel erkunden
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Phil Garner in United Kingdom
56 others named Phil Garner in United Kingdom are on LinkedIn
See others named Phil Garner